Switch to:
More From Other Websites
Gilead Sciences: Still Dominating Hepatitis C But… Aug 17 2016
ACHILLION PHARMACEUTICALS INC Financials Aug 12 2016
Is Achillion Pharmaceuticals (ACHN) Stock a Solid Choice Right Now? Aug 12 2016
Achillion Announces Upcoming Presentation of Interim Phase 2a Results From the Janssen Sponsored... Aug 11 2016
ETF’s with exposure to Achillion Pharmaceuticals, Inc. : August 9, 2016 Aug 09 2016
Achillion to Present at the 2016 Wedbush PacGrow Healthcare Conference Aug 09 2016
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACHN-US :... Aug 08 2016
Achillion Reports Second Quarter 2016 Financial Results Aug 04 2016
ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 04 2016
ACHILLION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 04 2016
Achillion Reports Second Quarter 2016 Financial Results Aug 04 2016
Q2 2016 Achillion Pharmaceuticals Inc Earnings Release - Tentative - Before Market Open Aug 04 2016
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACHN-US :... Jul 20 2016
Coverage initiated on Achillion Pharma by Chardan Capital Markets Jul 14 2016
5 Analyst Stock Picks Under $10 With Massive Upside Calls Jul 10 2016
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACHN-US :... Jul 08 2016
Achillion Pharmaceuticals (ACHN) Stock Up, JMP Upgrades Jul 07 2016
Analysts' Actions -- First Solar, Qualcomm, Red Hat, Zions and More Jul 07 2016
Achillion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ACHN) : June 21, 2016 Jun 21 2016
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACHN-US :... Jun 20 2016
Achillion Presents Interim Phase 1 Results for ACH-4471, a Novel Orally-Administered Factor D... Jun 10 2016
Achillion to Present at Three Upcoming Investor Conferences Jun 01 2016
Achillion Reports First Quarter 2016 Financial Results and Provides Update on Clinical Programs May 03 2016
Achillion reports 1Q loss May 03 2016
Achillion to Present at the Deutsche Bank 41st Annual Health Care Conference Apr 28 2016
Achillion beats Street 4Q forecasts Feb 25 2016
Achillion Appoints Dr. Joel Barrish as Chief Scientific Officer Jan 04 2016
Achillion Appoints Dr. Frank Verwiel to Board of Directors Dec 16 2015
Achillion Announces Upcoming Oral Presentation at the 57th Annual Meeting of the American Society of... Dec 05 2015
Achillion beats 3Q profit forecasts Nov 05 2015
Achillion Reports Third Quarter And Nine Month 2015 Financial Results Nov 05 2015
Achillion Announces Upcoming Oral Presentation at the 57th Annual Meeting of the American Society of... Nov 05 2015
Achillion Announces That Janssen Has Initiated a Phase 2a Study to Evaluate the Combination of... Oct 16 2015
Achillion Reports 100% SVR12 From Second Cohort of Patients in the Previously-Completed Six Week... Sep 17 2015
Achillion to Present at Two Upcoming Investor Conferences Sep 01 2015
Achillion reports 2Q loss Aug 10 2015
Achillion reports 1Q loss May 07 2015
Achillion shares soar following update on hepatitis C drug Feb 09 2015
Achillion rises on new hepatitis C drug study Dec 22 2014
Achillion rises on new hepatitis C drug study Nov 10 2014
Achillion beats 3Q profit forecasts Nov 04 2014
Achillion rises on hepatitis C drug study Aug 15 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK